Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 202

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

PD‐L1 expression in non‐small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens

Open access
Heymann, Jonas J., Bulman, William A., Swinarski, David, Pagan, Carlos A., Crapanzano, John P., Haghighi, Mehrvash, Fazlollahi, Ladan, Stoopler, Mark B., Sonett, Joshua R., Sacher, Adrian G., Shu, Catherine A., Rizvi, Naiyer A., Saqi, Anjali · 2017 · Cancer Cytopathology

Abstract

BACKGROUND: One immunotherapeutic agent for patients with advanced non‐small cell lung carcinoma, pembrolizumab, has a companion immunohistochemistry (IHC)‐based assay that predicts response by quantifying programmed death‐ligand 1 (PD‐L1) expression. The current study assessed the feasibility of quantifying PD‐L1 expression using cytologic non‐small cell lung carcinoma specimens and compared the results with those from small biopsy and surgical resection specimens. METHODS: PD‐L1 expression was quantified using the IHC‐based 22C3 pharmDx assay, with “positivity” defined as staining in ≥50% viable tumor cells; ≥ 100 tumor cells were required for test adequacy. For cytology specimens, IHC was performed on cell block sections. RESULTS: A total of 214 specimens were collected from 188 patients, 206 of which (96%) were found to be adequately cellular, including 36 of 40 cytology (90%) and 69 of 72 small biopsy (96%) specimens. There was no significant difference noted with regard to the feasibility of PD‐L1 IHC on small biopsy specimens compared with surgical resection specimens (P = .99), or between the percentage of PD‐L1‐positive cytology and histology (including surgical resection and histologic small biopsy) specimens (P = .083). PD‐L1 expression was found to be concordant among samples from 21 of 23 patients from whom > 1 specimen was collected (91%). There also was no significant difference observed with regard to rates of PD‐L1 positivity when comparing age, sex, diagnosis, and specimen site. CONCLUSIONS: Quantification of PD‐L1 expression is feasible on cytology specimens, and the results are comparable to those obtained from surgical resection and small biopsy specimens, including in matched specimens and using a single predictive IHC marker. Future studies will be necessary to determine the comparative value of other antibodies and their ability to predict response to immunotherapy. Cancer Cytopathol 2017;125:896‐907. © 2017 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncy.21937

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 202

Metadata

Authors
Heymann, J. J., Bulman, W. A., Swinarski, D., Pagan, C. A., Crapanzano, J. P., Haghighi, M., Fazlollahi, L., Stoopler, M. B., Sonett, J. R., Sacher, A. G., Shu, C. A., Rizvi, N. A., & Saqi, A.
Venue
Cancer Cytopathology
Publisher
Wiley
Published
2017-10-12
Volume
125
Issue
12
Pages
896-907
ISSN
  • 1934-662X (ISSN-L)
  • 1934-6638
OpenAlex
W2764262392
Cited by
202
References
12
FWCI
12.49
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PD‐L1 expression in non‐small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens. https://app.cochat.ai/papers/10.1002/cncy.21937
The paper
Heymann, J. J., Bulman, W. A., Swinarski, D., Pagan, C. A., Crapanzano, J. P., Haghighi, M., Fazlollahi, L., Stoopler, M. B., Sonett, J. R., Sacher, A. G., Shu, C. A., Rizvi, N. A., & Saqi, A. (2017). PD‐L1 expression in non‐small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens. Cancer Cytopathology. https://doi.org/10.1002/cncy.21937

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.